LEUKAEMIA (ACUTE MYELOID)

Clinical trials for LEUKAEMIA (ACUTE MYELOID) explained in plain language.

Never miss a new study

Get alerted when new LEUKAEMIA (ACUTE MYELOID) trials appear

Sign up with your email to follow new studies for LEUKAEMIA (ACUTE MYELOID), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Not yet finished but already full! 1

New drug combo aims to tame Tough-to-Treat blood cancer

Disease control Ongoing

This study is testing a combination of three drugs—gemtuzumab ozogamicin, cytarabine, and gilteritinib—for adults with a specific type of acute myeloid leukemia (AML) that has a FLT3 mutation and has come back or not responded to prior treatment. The main goals are to see if the …

Matched conditions: LEUKAEMIA (ACUTE MYELOID)

Phase: PHASE2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

LEUKAEMIA (ACUTE MYELOID)

Get alerted when new LEUKAEMIA (ACUTE MYELOID) trials appear

New drug combo aims to tame Tough-to-Treat blood cancer